NO20020008L - Anvendelse av cortisol antagonister i behandling av hjertesvikt - Google Patents

Anvendelse av cortisol antagonister i behandling av hjertesvikt

Info

Publication number
NO20020008L
NO20020008L NO20020008A NO20020008A NO20020008L NO 20020008 L NO20020008 L NO 20020008L NO 20020008 A NO20020008 A NO 20020008A NO 20020008 A NO20020008 A NO 20020008A NO 20020008 L NO20020008 L NO 20020008L
Authority
NO
Norway
Prior art keywords
treatment
heart failure
cortisol antagonists
cortisol
antagonists
Prior art date
Application number
NO20020008A
Other languages
English (en)
Other versions
NO20020008D0 (no
NO324395B1 (no
Inventor
Per Marin
Sten Sorensen
Original Assignee
Cortendo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortendo Ab filed Critical Cortendo Ab
Publication of NO20020008D0 publication Critical patent/NO20020008D0/no
Publication of NO20020008L publication Critical patent/NO20020008L/no
Publication of NO324395B1 publication Critical patent/NO324395B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20020008A 1999-07-02 2002-01-02 Anvendelse av ketoconazol ved fremstilling av et medikament til behandling av hjertesvikt NO324395B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9915625.9A GB9915625D0 (en) 1999-07-02 1999-07-02 Method
PCT/GB2000/002551 WO2001001971A1 (en) 1999-07-02 2000-07-03 Use of cortisol antagonists in the treatment for heat failure

Publications (3)

Publication Number Publication Date
NO20020008D0 NO20020008D0 (no) 2002-01-02
NO20020008L true NO20020008L (no) 2002-02-27
NO324395B1 NO324395B1 (no) 2007-10-01

Family

ID=10856599

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020008A NO324395B1 (no) 1999-07-02 2002-01-02 Anvendelse av ketoconazol ved fremstilling av et medikament til behandling av hjertesvikt

Country Status (16)

Country Link
US (1) US6881739B1 (no)
EP (1) EP1196152A1 (no)
JP (1) JP4039482B2 (no)
KR (1) KR100623166B1 (no)
AU (1) AU780152B2 (no)
CA (1) CA2375751A1 (no)
CZ (1) CZ300888B6 (no)
GB (1) GB9915625D0 (no)
HU (1) HUP0202339A3 (no)
MX (1) MXPA01013465A (no)
NO (1) NO324395B1 (no)
NZ (1) NZ516239A (no)
PL (1) PL202859B1 (no)
RU (1) RU2245712C2 (no)
SK (1) SK285845B6 (no)
WO (1) WO2001001971A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642236B1 (en) * 1998-12-14 2003-11-04 Cortendo Ab Methods for prophylactic treatment of cardiovascular disease with inhibitor of cortisol synthesis
SE0001899D0 (sv) 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds
GB0118300D0 (en) * 2001-07-26 2001-09-19 Cortendo Ab Formulations
EA200400707A1 (ru) 2001-11-22 2004-10-28 Биовитрум Аб Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
DE50213170D1 (de) * 2002-09-04 2009-02-12 Fraunhofer Ges Forschung Verwendung eines Mittel zur Therapie der Herzhypertrophie
CN101141964B (zh) * 2005-01-10 2013-06-05 科尔泰多投资公司 治疗糖尿病、代谢综合症和其它病症的组合物及方法
RU2009116632A (ru) 2006-10-02 2010-11-10 Кортендо Инвест, Аб (Se) Энантиомер кетоконазола у людей
WO2013103687A2 (en) * 2012-01-03 2013-07-11 Rhode Island Hospital Treatment of heart failure and sudden cardiac death

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US460314A (en) * 1891-09-29 George a
US4603141A (en) * 1984-11-30 1986-07-29 Giles Thomas D Oral clonidine treatment of congestive heart failure
US5175144A (en) * 1988-11-29 1992-12-29 The Johns Hopkins University Method of retarding the progression of chronic renal failure
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
GB9014221D0 (en) 1990-06-26 1990-08-15 Janssen Pharmaceutica Nv Method of treating alopecia
JP3918119B2 (ja) * 1993-01-21 2007-05-23 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 局所用ケトコナゾール組成物
US5565478A (en) * 1994-03-14 1996-10-15 The United States Of America As Represented By The Department Of Health & Human Services Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
RU2153873C2 (ru) * 1994-08-09 2000-08-10 Кортендо АБ Применение кетоконазола и родственных веществ в лекарствах, предназначенных для лечения диабета типа ii
US5756469A (en) * 1996-07-26 1998-05-26 Beale; Paxton K. Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
AU747956B2 (en) * 1997-10-06 2002-05-30 Board Of Trustees Of The Leland Stanford Junior University Methods for treating psychosis associated with glucocorticoid related dysfunction
SE9803272D0 (sv) 1998-09-25 1998-09-25 Kerstin Uvnaes Moberg A drug for cell regeneration
WO2000024402A1 (fr) * 1998-10-27 2000-05-04 Roumen Antonov Utilisation d'antifongiques dans le traitement des scleroses

Also Published As

Publication number Publication date
SK19332001A3 (sk) 2002-12-03
CZ20014684A3 (cs) 2002-11-13
CZ300888B6 (cs) 2009-09-02
RU2245712C2 (ru) 2005-02-10
NZ516239A (en) 2004-04-30
HUP0202339A3 (en) 2004-12-28
NO20020008D0 (no) 2002-01-02
PL202859B1 (pl) 2009-07-31
HUP0202339A2 (hu) 2002-11-28
JP2003503448A (ja) 2003-01-28
NO324395B1 (no) 2007-10-01
PL352479A1 (en) 2003-08-25
GB9915625D0 (en) 1999-09-01
MXPA01013465A (es) 2003-09-04
US6881739B1 (en) 2005-04-19
AU780152B2 (en) 2005-03-03
WO2001001971A1 (en) 2001-01-11
SK285845B6 (sk) 2007-09-06
AU5695600A (en) 2001-01-22
JP4039482B2 (ja) 2008-01-30
KR20020038600A (ko) 2002-05-23
KR100623166B1 (ko) 2006-09-11
EP1196152A1 (en) 2002-04-17
CA2375751A1 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
DE50009607D1 (de) Substituierte oxazolidinone und ihre verwendung im gebiet der blutgerinnung
NO20014524D0 (no) Rekombinant IL-18 antagonister anvendelige i behandling av IL- 18 medierte forstyrrelser
EE200300485A (et) Tiohüdantoinid ja nende kasutamine diabeedi raviks
DE60005810D1 (de) Fussstütze und möbelstück
IS5113A (is) Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
DE60020327D1 (de) Wasserbehandlungsvorrichtung
EE200200203A (et) Südame arütmia ravis kasutatavad uued oksabispidiinühendid
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
ATE232865T1 (de) 1,4-diazabicyclo(3.2.2)nonan-4-carboxylat und carboxamidderivate, ihre herstellung und therapeutische verwendung
DE60107859D1 (de) Benzimidazolderivate, ihre herstellung und therapeutische verwendung
DK1702618T3 (da) Brug af ET743 i kombinationsterapi med dexamethason til behandling af cancer
ATE231869T1 (de) Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung
EE05099B1 (et) Bradkardiaalsete toimeainete kasutamine hpertroofiaga seotud mokardiaalsete haiguste ravimiseks ja ravimikombinatsioonid
EE200200305A (et) Südame arütmiate ravis kasutatavad uued asabitsüklooktaani derivaadid
IS6137A (is) Meðhöndlun á hugsýkistruflunum
DE60017133D1 (de) Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose
EE200300364A (et) 3,7-diasabitsüklo[3,3,0]oktaanid ja nende kasutamine südame arütmiate ravis
NO20020008D0 (no) Anvendelse av cortisol antagonister i behandling av hjertesvikt
NO20023803D0 (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
EE200100527A (et) Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks
NO20011103D0 (no) Lokal avlevering av legemidler til hjertet
NO20001894L (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
EE200300013A (et) Bispidiini uued ühendid ning nende kasutamine südame arütmia ravis
IS2153B (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees